Drug or treatment
Erlotinib clinical trials
As of November 12, 2026, Find a Trial lists 5 clinical trials of Erlotinib that are recruiting, at sites in 3 countries (most in United States (3), Taiwan (1), China (1)). By phase: Phase 2 (3), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 3Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Methotrexate with erlotinib and celecoxib for recurrent or metastatic head and neck cancer in rural Midwest patients | Phase 2 | Rochester, Minnesota | Recruiting | May 30, 2025 |
| Treatment for advanced basal-like pancreatic cancer using a combination of drugs | Phase 1/2 | Chapel Hill, North Carolina | Recruiting | Jul 3, 2024 |
| Evaluating OBI-833/OBI-821 with Erlotinib for Lung Cancer | Phase 2 | Taipei, Beitou District and 6 other locations | Recruiting | Jul 1, 2022 |
| Combining three medications for advanced kidney cancer treatment | Phase 2 | La Jolla, California and 12 other locations | Recruiting | Jul 29, 2021 |
| Evaluating EGFR-TKI treatments in lung cancer patients | — | Guangzhou, Guangdong | Recruiting | Nov 25, 2013 |
All recruiting trials (5)
-
Methotrexate with erlotinib and celecoxib for recurrent or metastatic head and neck cancer in rural Midwest patients
This trial tests whether combining methotrexate, erlotinib, and celecoxib can help adults in the rural Midwest whose head and neck cancer has returned or spread.
-
Treatment for advanced basal-like pancreatic cancer using a combination of drugs
This study is testing a new combination of drugs to see if it can help people with advanced basal-like pancreatic cancer feel better when standard treatments aren't working.
-
Evaluating OBI-833/OBI-821 with Erlotinib for Lung Cancer
This study is testing if adding two new treatments, OBI-833 and OBI-821, to the standard lung cancer drug erlotinib can help people with a specific type of lung cancer feel better and live longer.
-
Combining three medications for advanced kidney cancer treatment
This study is testing a combination of three medications to see if they can help people with advanced kidney cancer feel better and live longer.
-
Evaluating EGFR-TKI treatments in lung cancer patients
This study is testing how well different EGFR-TKI treatments work for people with advanced lung cancer and looking at how genetic factors and drug levels affect their results.
Quick answers
How many clinical trials of Erlotinib are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (3 trials), Taiwan (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.